World

Nasal cells help paralyzed man make history by walking

Bloomberg News
By Bloomberg News
3 Min Read Oct. 21, 2014 | 12 years Ago
Go Ad-Free today

A man paralyzed from the chest down in a knife attack is walking again as a result of undergoing surgery using cells responsible for the sense of smell, marking an advance in the search for treatments for spinal injuries.

Darek Fidyka, 38, received the cells after failing to recover from a stabbing in the back in 2010, according to University College London, whose doctors developed the procedure. The technique involves using olfactory ensheathing cells and placing them in the spinal cord.

The study gives hope to the thousands of people each year who suffer a severe spinal cord injury and must live the rest of their lives with permanently damaged body functions. Such injuries typically occur during sports or automobile crashes and there is no approved treatment to repair them.

“We have now opened the door to a treatment of spinal cord injury that will get patients out of wheelchairs,” said Geoffrey Raisman, chairman of neural regeneration at the UCL Institute of Neurology and leader of the British research team. “Our goal now is to develop this first procedure to a point where it can be rolled out as a worldwide general approach.”

The cells used were discovered by Raisman in 1985 and were shown to work in treating spinal injuries in rats in 1997. They allow nerve cells that give people their sense of smell to grow back when they are damaged. The procedure on Fidyka was performed by surgeons at Wroclaw University Hospital in Poland.

For the treatment, Fidyka underwent brain surgery to remove an olfactory bulb, a structure responsible for the sense of smell. The bulb was placed in a cell culture for two weeks to produce olfactory cells, which were injected into the spinal cord along with four strips of nerve tissue taken from the ankle. The strips formed bridges for the spinal nerve fibers to grow across, with the aid of the cells.

Three months after the surgery, Fidyka's left thigh muscle began to grow and after six months he was starting to walk within the rehabilitation center with the help of a physiotherapist and leg braces, according to UCL. His bladder sensation and sexual function have improved.

“This technology has been confined to labs, so it's promising to see that it may have helped someone recover from a clean cut through the spinal cord,” said Jeremy Fairbank, a professor of spine surgery at the University of Oxford who wasn't involved in the research.

“The next question is what sort of clinical experiments must be done to prove that this works,” Fairbank said. “I suspect it will take years until there is a practical way of doing this.”

The research, funded by Britain's Stem Cell Foundation and the Nicholls Spinal Injury Foundation, was published in the Cell Transplantation journal. Further studies in patients are planned by UCL and Wroclaw University Hospital, according to Michael Hanna, director of the UCL Institute of Neurology.

“It's as if you were born again,” the patient, who can now walk using a walker, said in a statement from University College London.

Experts not directly involved in the work said its results offered some new hope, but said more work needed to be done to figure out what had led to this success, and more patients treated, before its potential could be properly assessed.

“While this study is only in one patient, it provides hope of a possible treatment for restoration of some function in individuals with complete spinal cord injury,” said John Sladek, a professor of neurology and paediatrics at the University of Colorado School of Medicine.

Reuters contributed to this report.

Share

About the Writers

Push Notifications

Get news alerts first, right in your browser.

Enable Notifications

Enjoy TribLIVE, Uninterrupted.

Support our journalism and get an ad-free experience on all your devices.

  • TribLIVE AdFree Monthly

    • Unlimited ad-free articles
    • Pay just $4.99 for your first month
  • TribLIVE AdFree Annually BEST VALUE

    • Unlimited ad-free articles
    • Billed annually, $49.99 for the first year
    • Save 50% on your first year
Get Ad-Free Access Now View other subscription options